Promising practices for the prevention of liver cancer: a review of the literature and cancer plan activities in the National Comprehensive Cancer Control Program
- 102 Downloads
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are risk factors for hepatocellular carcinoma, a type of primary liver cancer, and are most prevalent in people born 1945–1965. Relatively little information is available for liver cancer prevention, compared to other cancers. In this review, we provide a summary of current promising public health practices for liver cancer prevention from the literature, as well as liver cancer-related initiatives in the National Comprehensive Cancer Control Program (NCCCP).
Two types of source materials were analyzed for this review: published literature (2005-present), and current cancer plans from the NCCCP (2005–2022). A search strategy was developed to include a review of several scientific databases. Of the 73 articles identified as potentially eligible, 20 articles were eligible for inclusion in the review. Eligible articles were abstracted using a data abstraction tool. Three independent keyword searches on 65 NCCCP plans were conducted. Keyword searches within each of the plans to identify activities related to liver cancer were conducted. Relevant information was abstracted from the plans and saved in a data table.
Of the 20 eligible articles, 15 articles provided information on interventions related to liver cancer and hepatitis B or hepatitis C prevention. All 15 of the intervention articles were related to hepatitis; 13 were hepatitis B-focused, two were hepatitis C-focused, and 14 focused on Asian/Pacific Islander American populations. The independent keyword search of NCCCP plans produced 46 results for liver, 27 results for hepatitis, and 52 results for alcohol. Two plans included activities related to liver cancer. Twenty-four plans included activities related to hepatitis.
A majority of the intervention articles published focused on HBV infection in Asian/Pacific Islander American populations, and a small percentage of NCCCP plans included liver-related content. The findings from this review will inform the development of an Action Plan on liver cancer prevention for the NCCCP, which will assist programs with the adoption and uptake of promising practices for the prevention of liver cancer.
KeywordsComprehensive cancer control Carcinoma Hepatocellular Primary prevention Health promotion
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 2.U.S. Cancer Statistics Working Group (2017) United States Cancer Statistics: 1999–2014 incidence and mortality web-based report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta. http://www.cdc.gov/uscs
- 9.National Comprehensive Cancer Control Program (NCCCP). https://www.cdc.gov/cancer/ncccp/index.htm. Accessed Sept 2017
- 15.Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A et al (2008) Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 57(RR-8):1–20Google Scholar
- 21.Hsu CE, Zhang G, Yan FA, Shang N, Le T (2010) What made a successful hepatitis B program for reducing liver cancer disparities: an examination of baseline characteristics and educational intervention, infection status, and missing responses of at-risk Asian Americans. J Community Health 35(3):325–335CrossRefGoogle Scholar
- 33.CDC Yellowbook. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/hepatitis-b. Accessed 23 Oct 2018
- 34.Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM, for the High Value Care Task Force of the American College of Physicians and the Centers for Disease Control and Prevention (2017) Hepatitis B, vaccination screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med 167:794–804. https://doi.org/10.7326/M17-1106 CrossRefPubMedGoogle Scholar
- 35.U.S. Preventive Services Task Force (2014) Final recommendation statement: hepatitis B, non-pregnant adolescents and adults, May 2014. U.S. Preventive Services Task Force, Rockville. Retrieved January 18, 2016, from http://www.uspreventiveservicestaskforce.org/Page/Document/Recommendation StatementFinal/hepatitis-b-virus-infection-screening-2014
- 36.Millman AJ et al (2017) Barriers to treatment access for chronic hepatitis C virus infection: a case series. Top Antiviral Med 25(3):110Google Scholar
- 37.Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG et al (2012) Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep 61(RR-4):1–32Google Scholar
- 38.Moyer VA (2013) Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 159(5):349–357. https://doi.org/10.7326/0003-4819-159-5-201309030-00672 CrossRefPubMedGoogle Scholar
- 40.Centers for Disease Control and Prevention. https://www.cdc.gov/cancer/liver/index.htm. Accessed on 23 Oct 2018